Yanxiang Zhang
Hebei Medical University(CN)Simcere Pharmaceutical (China)(CN)First Affiliated Hospital of Hebei Medical University(CN)China Agricultural University(CN)
Publications by Year
Research Areas
Nanoplatforms for cancer theranostics, IoT and Edge/Fog Computing, Cancer Research and Treatments, Cancer Genomics and Diagnostics, Drug-Induced Hepatotoxicity and Protection
Most-Cited Works
- → A Neural Network Framework for Predicting the Tissue-of-Origin of 15 Common Cancer Types Based on RNA-Seq Data(2020)83 cited
- → Health related quality of life in stroke patients and risk factors associated with patients for return to work(2019)67 cited
- → Pleiotropic Immunomodulatory Functions of Radioactive Inactivated Bacterial Vectors for Enhanced Cancer Radio-immunotherapy(2022)65 cited
- → Suppression of miR-155 attenuates neuropathic pain by inducing an M1 to M2 switch in microglia(2020)51 cited
- → Metabolic Homeostasis‐Regulated Nanoparticles for Antibody‐Independent Cancer Radio‐Immunotherapy(2022)51 cited
- → Iodine-Rich Polymersomes Enable Versatile SPECT/CT Imaging and Potent Radioisotope Therapy for Tumor in Vivo(2019)49 cited